# Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

> **NCT06379958** · PHASE1 · RECRUITING · sponsor: **Modern Biosciences Ltd** · enrollment: 48 (estimated)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** leramistat 40mg
- **DRUG:** Itraconazole 200 mg
- **DRUG:** Phenytoin 100 Mg Oral Capsule
- **DRUG:** Simvastatin 40mg
- **DRUG:** Upadacitinib 15 MG

## Key facts

- **NCT ID:** NCT06379958
- **Lead sponsor:** Modern Biosciences Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-08
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06379958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06379958, "Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06379958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*